Magali Volteau

1.4k total citations
30 papers, 927 citations indexed

About

Magali Volteau is a scholar working on Neurology, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Magali Volteau has authored 30 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 12 papers in Psychiatry and Mental health and 6 papers in Oncology. Recurrent topics in Magali Volteau's work include Botulinum Toxin and Related Neurological Disorders (16 papers), Dementia and Cognitive Impairment Research (7 papers) and Stroke Rehabilitation and Recovery (4 papers). Magali Volteau is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (16 papers), Dementia and Cognitive Impairment Research (7 papers) and Stroke Rehabilitation and Recovery (4 papers). Magali Volteau collaborates with scholars based in France, United States and Germany. Magali Volteau's co-authors include Bruno Dubois, Sylvie Legrain, Claudine Berr, Marie Sarazin, Philippe Robert, Michel Benoît, Michèle Puel, J. Touchon, Jocelyne de Rotrou and Bernard François Michel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and European Urology.

In The Last Decade

Magali Volteau

27 papers receiving 903 citations

Peers

Countries citing papers authored by Magali Volteau

Since Specialization

Citations

This map shows the geographic impact of Magali Volteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Volteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Volteau more than expected).

Fields of papers citing papers by Magali Volteau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magali Volteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Volteau. The network helps show where Magali Volteau may publish in the future.

Co-authorship network of co-authors of Magali Volteau

This figure shows the co-authorship network connecting the top 25 collaborators of Magali Volteau. A scholar is included among the top collaborators of Magali Volteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magali Volteau. Magali Volteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 2 randomized study of abobotulinumtoxinA in patients with provoked vestibulodynia: dose-finding results 2025 ·The Journal of Sexual Medicine ·Andrew T. Goldstein, Rachel Rubin, (unknown), Irwin Goldstein, Brooke Faught, Nina Bohm‐Starke, Jill M. Krapf, (unknown), Magali Volteau, Robert Silva	0
2	Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Uta Eberlein, C. Ansquer, Jean‐Mathieu Beauregard, (unknown), Henning Grønbæk, Alexander Haug, Rodney J. Hicks, Nat Lenzo, Shaunak Navalkissoor, Guillaume Nicolas, (unknown), Magali Volteau, Damian Wild, Alexander McEwan, Michael Laßmann	6
3	Exploring the Relationship Between Clinical Presentation in Hallux Valgus and Response to AbobotulinumtoxinA Treatment 2023 ·The Journal of Foot & Ankle Surgery ·(unknown), Lawrence A. DiDomenico, Magali Volteau, David G. Armstrong, Robert Silva	0
4	A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Damian Wild, Henning Grønbæk, Shaunak Navalkissoor, Alexander Haug, Guillaume Nicolas, (unknown), C. Ansquer, Jean‐Mathieu Beauregard, Alexander McEwan, Michael Laßmann, (unknown), Magali Volteau, Nat Lenzo, Rodney J. Hicks	17
5	Goal Attainment after Treatment with Abobotulinumtoxina and a Tailored Home Therapy Programme in Children with Upper Limb Spasticity: Descriptive, Exploratory Analysis of a Large Randomized, Controlled Study 2022 ·Journal of Rehabilitation Medicine ·(unknown), Nigar Dursun, (unknown), Marcin Bonikowski, (unknown), Edward Dabrowski, Ann Tilton, Joyce Oleszek, Magali Volteau, (unknown), (unknown), Mauricio R. Delgado	1
6	Pain Reduction With AbobotulinumtoxinA for the Treatment of Hallux Valgus in Adult Participants: Results of a Randomized and Placebo-Controlled Phase 2 Trial 2022 ·The Journal of Foot & Ankle Surgery ·David G. Armstrong, Lawrence A. DiDomenico, (unknown), Selene G. Parekh, Magali Volteau, Robert Silva	1
7	Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2) 2022 ·European Urology ·Michael Kennelly, Francisco Cruz, Sender Herschorn, Paul Abrams, Kadir Önem, (unknown), (unknown), (unknown), Antonella Giannantoni, Catherine Thompson, Claire Vilain, Magali Volteau, P. Denys	17
8	Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport®) 2019 ·Journal of the Neurological Sciences ·Laurent Pons, Claire Vilain, Magali Volteau, Philippe Picaut	23
9	Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial 2019 ·Aesthetic Surgery Journal ·Benjamin Ascher, Berthold Rzany, Philippe Kestemont, Said Hilton, Marc Heckmann, Isaac Bodokh, Ernst Magnus Noah, (unknown), Martina Kerscher, Magali Volteau, (unknown), Philippe Picaut	18
10	Assessment of Bowel Preparation Using Low-Volume Sulphate-Based Preparations in Comparison with Macrogols: A Multicenter, Randomized, Comparative Clinical Study of the 3rd Phase 2019 ·SHILAP Revista de lepidopterología ·Е. Д. Федоров, В. В. Веселов, С. В. Кашин, (unknown), А. V. Veselov, D. V. Zav’yalov, (unknown), (unknown), Magali Volteau, Thierry Ponchon	4
11	AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin 2018 ·Pediatric Neurology ·Edward Dabrowski, Marcin Bonikowski, Mark Gormley, Magali Volteau, Philippe Picaut, Mauricio R. Delgado	4
12	Dose‐Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study 2017 ·PM&R ·Michael W. O’Dell, Allison Brashear, Robert Jech, Thierry Lejeune, P. Marqué, Djamel Bensmaïl, (unknown), David M. Simpson, Magali Volteau, Claire Vilain, Philippe Picaut, (unknown)	12
13	Quantitative Effects of Botulinum Toxin Treatment on the Modified Ashworth Scale and the Tardieu Scale: Results from a Randomized Controlled Study of AbobotulinumtoxinA in Children with Dynamic Equinus Foot Deformity due to Cerebral Palsy (S10.006) 2016 ·Neurology ·Ann Tilton, Edward Dabrowski, Dennis J. Matthews, Mark Gormley, (unknown), Magali Volteau, Philippe Picaut	1
14	Unawareness of memory impairment and behavioral abnormalities in patients with Alzheimer's disease: Relation to professional health care burden 2011 ·The journal of nutrition health & aging ·(unknown), (unknown), Philippe Thomas, Magali Volteau, (unknown), Gianfranco Dalla Barba	24
15	Progeny's mental aptitudes in man: relationship with parental age at conception and with some environmental factors 2009 ·Comptes Rendus Biologies ·M Auroux, Magali Volteau, B. Ducot, (unknown), Alexia Letierce, Laurence Meyer, Marie-Jeanne Mayaux	9
16	Early detection of patients in the pre demented stage of Alzheimer's disease: The Pre-Al study 2009 ·The journal of nutrition health & aging ·Florence Mahieux, Fannie Onen, Claudine Berr, Magali Volteau, Marie‐Odile Habert, Sylvie Legrain, Bruno Dubois	14
17	Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia 2008 ·Journal of the Neurological Sciences ·Éric Guedj, Gilles Allali, Celine Goetz, Isabelle Le Ber, Magali Volteau, Lucette Lacomblez, Pierre Véra, Anne Hitzel, Didier Hannequin, M. Décousus, Catherine Thomas-Antérion, C. Magne, Martine Vercelletto, Anne‐Marie Bernard, Mira Didic, Jean-Albert Lotterie, Michèle Puel, Alexis Brice, Marie-Odile Habert, Bruno Dubois	68
18	Importance of Lack of Interest in Patients With Mild Cognitive Impairment 2008 ·American Journal of Geriatric Psychiatry ·Philippe Robert, Claudine Berr, Magali Volteau, (unknown), Michel Benoît, Olivier Guérin, Marie Sarazin, Sylvie Legrain, Bruno Dubois	78
19	Neuropsychological Performance in Mild Cognitive Impairment with and without Apathy 2006 ·Dementia and Geriatric Cognitive Disorders ·Philippe Robert, Claudine Berr, Magali Volteau, C. Bertogliati, Michel Benoît, Florence Mahieux, Sylvie Legrain, Bruno Dubois	64
20	Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease 2006 ·Clinical Neurology and Neurosurgery ·Philippe Robert, Claudine Berr, Magali Volteau, C. Bertogliati, Michel Benoît, Marie Sarazin, Sylvie Legrain, Bruno Dubois	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact